Although faecal microbiota transplantation (FMT) has a well-established role in the treatment
of recurrent Clostridioides difficile infection (CDI), its widespread dissemination is limited by …

Background & Aims Fecal microbiota transplantation (FMT) is used commonly for treatment
of Clostridioides difficile infections (CDIs), although prospective safety data are limited and …

Background Fecal bacteriotherapy (FB) has been proposed as a safe and effective alternative
treatment for a number of gastrointestinal conditions including ulcerative colitis (UC). We …

Background & Aims Fecal microbiota transplantation (FMT) is commonly used to treat
Clostridium difficile infection (CDI). CDI is an increasing cause of diarrheal illness in pediatric …

Fecal microbiota transplantation (FMT) is becoming part of the treatment algorithms against
recurrent Clostridium difficile infection (rCDI) both in adult and pediatric gastroenterology …

Chronic inflammatory disorders are thought to arise due to an interplay between predisposing
host genetics and environmental factors. For example, the onset of inflammatory bowel …

Background Fecal microbiota transplantation (FMT), the delivery of stool from a healthy
prescreened donor to an individual with disease, is gaining increasing recognition as a potential …

Background Fecal microbiota transplantation (FMT) is an effective treatment for recurrent
Clostridium difficile infection and shows promise for treating other medical conditions …

Background Persistent active endoscopic and histological inflammation is associated with
poorer outcomes in ulcerative colitis (UC). Fecal calprotectin is a surrogate marker of …

(CDI) had a primary cure rate of 91%, a secondary cure rate of 98%, and no serious
adverse events. Their findings highlight not only the remarkable efficacy of FMT but also the …